Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Saad Zafar Usmani"'
Autor:
Thierry Facon, Shaji Kumar, Torben Plesner, Philippe Moreau, Nizar J. Bahlis, Hartmut Goldschmidt, Michael O'Dwyer, Aurore Perrot, Christopher P. Venner, Katja Weisel, Joseph R. Mace, Noopur S. Raje, Mourad Tiab, Margaret Macro, Laurent Frenzel, Xavier Leleu, Huiling Pei, Fredrik Borgsten, Saad Zafar Usmani
Publikováno v:
Journal of Clinical Oncology. 40:8044-8044
8044 Background: In the phase 3 MAIA study, adding DARA to Rd improved progression-free survival (primary endpoint), overall survival, duration of response, and PROs in transplant-ineligible pts with NDMM. We report a MAIA subgroup analysis of time t
Autor:
Mufti Naeem Ahmad, Sairah Ahmed, Shukaib Arslan, Farrukh T. Awan, Qaiser Bashir, Didier Blaise, Megan Bodge, Stefania Bramanti, Luca Castagna, Luciano J. Costa, Aaron Cumpston, Anita D’Souza, Marcos de Lima, Raynier Devillier, Rebecca Devlin, Fiona L. Dignan, Sabine Furst, Ragisha Gopalakrishnan, Alison Gulbis, Vikas Gupta, Ali Haider, Parameswaran Hari, Chitra Hosing, Mohammed Junaid Hussain, Racquel Innis-Shelton, Madan Jagasia, Abraham S. Kanate, Partow Kebriaei, Maliha Khan, Shakila P. Khan, Mohamed A. Kharfan-Dabaja, Sola Kim, Mira A. Kohorst, Amrita Krishnan, Rohtesh S. Mehta, Muhammad Ayaz Mir, Ravi Kishore Narra, Nhu-Nhu Nguyen, Yago Nieto, Liana Nikolaenko, Amanda Olson, Kelly E. Pillinger, Chelsea C. Pinnix, L.M. Poon, Kelly G. Ross, Muhammad A. Saif, Nirav N. Shah, Zainab Shahid, Bronwen E. Shaw, Elizabeth J. Shpall, Rabbia Siddiqi, Roni Tamari, Benjamin Tomlinson, Saad Zafar Usmani, Lauren Veltri, Daniel Weisdorf, Ibrahim Yakoub-Agha, Lily Yan
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c6ac12c92007eadfdd5c803223614860
https://doi.org/10.1016/b978-0-323-56802-9.01002-6
https://doi.org/10.1016/b978-0-323-56802-9.01002-6
Autor:
Saad Zafar Usmani, Fredrik Schjesvold, Albert Oriol, Lionel Karlin, Michele Cavo, Robert M Rifkin, Habte Aragaw Yimer, Richard LeBlanc, Naoki Takezako, Robert Donald McCroskey, Andrew Boon Ming Lim, Kenshi Suzuki, Hiroshi Kosugi, George Grigoriadis, Irit Avivi, Thierry Facon, Sundar Jagannath, Sagar Lonial, Razi Uddin Ghori, Mohammed Z H Farooqui, Patricia Marinello, Jesus San-Miguel, Andrew Lim, Trish Walker, Andrew Nicol, Donna Reece, Mohamed Elemary, Jean Samuel Boudreault Pedneault, Michel Attal, Katja Weisel, Monika Engelhardt, Andreas Mackensen, John Quinn, Amos Cohen, Hila Magen-Nativ, Noam Benyamini, Alessandra Larocca, Morio Matsumoto, Shinsuke Iida, Takayuki Ishikawa, Yukio Kondo, Kazutaka Sunami, Kiyoshi Ando, Takanori Teshima, Takaaki Chou, Hiromi Iwasaki, Hirokazu Miki, Itaru Matsumura, Yasushi Onishi, Koji Izutsu, Masahiro Kizaki, Anupkumar George, Hillary Blacklock, David Simpson, Anders Waage, Olga Samoilova, Evgeniy Nikitin, Tatiana Chagorova, Andrew McDonald, Moosa Patel, Albert Oriol Rocafiguera, Jesus San Miguel Izquierdo, Maria Mateos, Matthew Streetly, Peter Forsyth, Graham Jackson, Stephen Jenkins, Robert Rifkin, Habte Yimer, Robert McCroskey, Danko Martincic, Stefano Tarantolo, Sarah Larson, Yacoub Faroun, Jennifer Vaughn, Rachid Baz, Gene Saylors, Amarendra Neppalli, Anastasios Raptis, Henry Fung, Maxwell Janosky, Don Stevens, Morton Coleman, Dennis Costa, Scott Cross, Suzanne Fanning, Daniel Farray Berges, Thomas Harris, Ira Zackon, Djordje Atanackovic, Kelvin Lee, Ira Oliff, Wes Lee, William Bensinger, Jose Lutzky, Ari Baron, Fadi Hayek, Eli Kirschner, Neeraj Bharany, Lindsay Overton, Siva Mannem, Allyson Harroff, Sharad Jain, Tammy Roque, Kristi McIntyre, Christopher K Yasencha, William Houck
Publikováno v:
Lancet Haematology
r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
instname
r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
instname
Summary Background Lenalidomide and dexamethasone has been a standard of care in transplant-ineligible patients with newly diagnosed multiple myeloma. The addition of a third drug to the combination is likely to improve treatment efficacy. KEYNOTE-18
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9587f7fc06343c5e2bc999bbff275d45
http://hdl.handle.net/10852/77065
http://hdl.handle.net/10852/77065
Publikováno v:
Journal of clinical apheresis. 29(5)
Mobilization regimens for CD34+ cells have generally been judged successful based on the number of cells collected without evaluating mobilization separately from collection. Using retrospective data for patients who collected CD34+ cells on Total Th
Publikováno v:
Asian Pacific journal of cancer prevention : APJCP. 8(2)
Primary lymphoma of genitourinary system is rare as these organs do not contain lymphoid tissue, however secondary involvement often occurs. The most commonly affected genitourinary organ is the kidney.Medical records of 901 patients with documented